Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 221,894,024 papers from all fields of science
Search
Sign In
Create Free Account
MAGE-3.A1 Peptide Vaccine
Known as:
HLA-A1-Restricted MAGE-3 Peptide Vaccine
, MAGE-3.A1
A synthetic peptide cancer vaccine consisting of human leukocyte antigen HLA-A1-restricted peptide derived from human melanoma antigen 3 (MAGE-3…
Expand
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
1 relation
Antigen Sensitization
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Analysis of a rare melanoma patient with a spontaneous CTL response to a MAGE-A3 peptide presented by HLA-A1
T. Hanagiri
,
N. Baren
,
B. Neyns
,
T. Boon
,
P. Coulie
Cancer Immunology and Immunotherapy
2006
Corpus ID: 11244054
We describe an HLA-A1 melanoma patient who has mounted a spontaneous cytolytic T cell (CTL) response against an antigenic peptide…
Expand
2004
2004
Immunization of melanoma patients with a MAGE-3 peptide combined with IFNa.
J. Baurain
,
N. van Baren
,
+5 authors
P. Coulie
Journal of Clinical Oncology
2004
Corpus ID: 24542529
2606 Background: Melanoma patients with lymph node metastasis at diagnosis have a less than 60% survival rate at 5 years…
Expand
1998
1998
Intralesional selection of T cell clonotypes in the immune response to melanoma antigens occurring during vaccination.
M. Sensi
,
Cinthia Farina
,
C. Maccalli
,
A. Anichini
,
D. Berd
,
Giorgio Parmiani
Journal of immunotherapy
1998
Corpus ID: 19698506
T cells infiltrating pre- and postvaccine metastases obtained from melanoma patients vaccinated with either dinitrophenyl (DNP…
Expand
1998
1998
Analysis of the degradation mechanisms of MHC class I-presented tumor antigenic peptides by high performance liquid chromatography/electrospray ionization mass spectrometry: application to the design…
M. Ayyoub
,
B. Monsarrat
,
H. Mazarguil
,
J. Gairin
Rapid Communications in Mass Spectrometry
1998
Corpus ID: 36232115
Peptide vaccines based on the use of MHC class I restricted epitopes are currently assayed for anti-tumor and anti-viral…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE